Enliven Therapeutics

Enliven Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing innovative small molecule inhibitors for cancer patients. Their mission is to not only extend lives but also improve the quality of life for those battling the disease. Enliven's approach focuses on precision oncology, addressing unmet needs with therapies that enhance efficacy through better selectivity and combinability, combat resistance, address brain metastases, and improve safety and patient convenience.

Enliven currently has two lead product candidates, ELVN-001 and ELVN-002, both of which are in Phase 1 clinical trials. ELVN-001 targets the BCR-ABL gene fusion, a driver of chronic myeloid leukemia (CML), while ELVN-002 is a highly selective and CNS-penetrant HER2 inhibitor designed to address aggressive solid tumors. Enliven's team is composed of seasoned drug hunters with extensive experience in the discovery and development of kinase inhibitors, ensuring their programs are advanced to greater levels.

Enliven Therapeutics offers remote work opportunities, as evidenced by the "Manager / Senior Manager, Clinical Supply Chain" job posting which is listed as being remote. While the website does not explicitly state a company-wide policy regarding flexible work arrangements, the remote job posting suggests that the company may be open to flexible work arrangements for certain roles.

Enliven Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing small molecule inhibitors that improve the lives of cancer patients. Their mission is to help patients not only live longer, but live better by addressing existing and emerging unmet needs in oncology with a precision medicine approach. They strive to design therapies that enhance survival, combat drug resistance, and improve overall well-being for patients with cancer.

Enliven Therapeutics promotes an inclusive and collaborative culture driven by integrity, passion, and a commitment to helping cancer patients live longer and better. They value diverse perspectives, encourage open communication, and prioritize teamwork to achieve their ambitious goals. This collaborative spirit is fostered by a strong sense of purpose, fueled by their dedication to developing innovative therapies and contributing to the advancement of precision oncology.

Enliven Therapeutics prioritizes an inclusive and collaborative culture that values diversity of thought and experience. They are committed to fostering a workplace where all individuals feel respected, valued, and empowered to contribute their unique talents. This commitment is reflected in their company values, which emphasize integrity, passion, collaboration, and drive.